@prefix dct: .
@prefix this: .
@prefix sub: .
@prefix beldoc: .
@prefix rdfs: .
@prefix rdf: .
@prefix xsd: .
@prefix dce: .
@prefix pav: .
@prefix np: .
@prefix belv: .
@prefix prov: .
@prefix chebi: .
@prefix Protein: .
@prefix sfam: .
@prefix geneProductOf: .
@prefix rgd: .
@prefix obo: .
@prefix occursIn: .
@prefix species: .
@prefix pubmed: .
@prefix orcid: .
sub:Head {
this: np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubinfo;
a np:Nanopublication .
}
sub:assertion {
sub:_1 geneProductOf: sfam:PDGF%20Family;
a Protein: .
sub:_2 geneProductOf: rgd:69328;
a Protein: .
sub:_3 rdf:object sub:_2;
rdf:predicate belv:increases;
rdf:subject sub:_1;
a rdf:Statement .
sub:_4 occursIn: obo:UBERON_0000947, species:10116;
rdf:object sub:_3;
rdf:predicate belv:decreases;
rdf:subject chebi:9753;
a rdf:Statement .
sub:assertion rdfs:label "a(CHEBI:troglitazone) -| (p(SFAM:\"PDGF Family\") -> p(RGD:Cdkn1a))",
"p(SFAM:\"PDGF Family\") -> p(RGD:Cdkn1a)" .
}
sub:provenance {
beldoc: dce:description "Approximately 61,000 statements.";
dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved.";
dce:title "BEL Framework Large Corpus Document";
pav:authoredBy sub:_6;
pav:version "20131211" .
sub:_5 prov:value "PPARgamma ligands troglitazone (TRO, 10 microm) and rosiglitazone (RSG, 10 microm) attenuated the induction of p21(Cip1) protein by platelet-derived growth factor (PDGF) and insulin without affecting cognate mRNA levels in rat aortic smooth muscle cells (RASMC).";
prov:wasQuotedFrom pubmed:11598137 .
sub:_6 rdfs:label "Selventa" .
sub:assertion prov:hadPrimarySource pubmed:11598137;
prov:wasDerivedFrom beldoc:, sub:_5 .
}
sub:pubinfo {
this: dct:created "2014-07-03T14:31:44.146+02:00"^^xsd:dateTime;
pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 .
}